Biopharmaceuticals

South San Francisco, California, August 13, 2026 Rigel Pharmaceuticals, Inc. announced the U.S. commercial availability of VEPPANU™ (vepdegestrant) for...

Miami, Florida, August 12, 2026 Summit Therapeutics announced that its partner Akeso Inc. received marketing authorization from China’s National...

Shanghai, China, August 12, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that China’s National Medical Products Administration (NMPA)...

Warren, New Jersey, August 12, 2026 PTC Therapeutics announced that it was selected as the winning bidder to acquire...

LONDON, UK; SOLANA BEACH, California; and AHMEDABAD, India, August 11, 2026 Mereo BioPharma Group plc and Sentynl Therapeutics, Inc.,...

TEL AVIV, Israel, August 11, 2026 Teva Pharmaceutical Industries Ltd. announced that Moody’s Ratings has upgraded the company’s corporate...

SARASOTA, Fla., August 10, 2026 Silo Pharma, Inc. announced that the European Patent Office (EPO) has granted a patent...

London, August 10, 2026 Silence Therapeutics plc announced positive topline results from the Phase 2 SANRECO trial of divesiran...

San Carlos, Calif. & Redwood City, Calif., August 10, 2026 BeOne Medicines Ltd. and Revolution Medicines, Inc. announced a...

Barcelona, Spain, August 9, 2026 Almirall announced a collaboration and licensing agreement with CrystalO, a China-based biotechnology company, to...